Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Alopecia areata causes negative emotions and stress due to hair loss and emotional triggers.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Alopecia areata may be caused by the immune system attacking hair follicles.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Alopecia areata in children often leads to anxiety, depression, and other mental health issues, affecting their quality of life.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Direct patients with alopecia areata to Alopecia UK, the National Alopecia Areata Foundation, and Health Talk for the best online psychological support.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Certain types of alopecia areata are linked to allergies, autoimmune diseases, and family history.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Etanercept may not prevent alopecia areata from coming back.

Dupilumab may help regrow hair in people with atopic dermatitis.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.